Torrent Pharma gets Form 483 with observation from USFDA for Pithampur plant
The drug maker will respond to the USFDA within the prescribed timeframe and will work in close collaboration with it to ...
Eli Lilly wants records of people who took copies of its weight-loss drug
“I am gobsmacked that Lilly is seeking confidential patient medical records to build a case against the very therapies that ...
U.S. FDA declines to approve Vanda's stomach paralysis drug
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
money.rediff48m
Torrent Pharma Gets USFDA Form 483 for Pithampur Plant
Torrent Pharmaceuticals received a Form 483 with one observation from the USFDA after an inspection of its Pithampur ...
FDA rejects Vanda Pharmaceuticals' application to bring key drug to market
A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...
Republic Business on MSN9m
Torrent Pharma receives USFDA form 483 with observation for Pithampur manufacturing facility
Torrent Pharmaceuticals, a leading player in the pharmaceutical industry, announced on Friday that it has received a Form 483 ...
FDA Rejects Vanda Pharma's Application for Gastroparesis Drug Tradipitant
Vanda said it will continue to pursue approval of tradipitant in gastroparesis, a condition that affects the stomach muscles and prevents proper stomach emptying, and that it plans to file a separate ...
Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved ...
Dairy Herd20h
FDA Approves 5 New Dairy Drugs
The U.S. Food and Drug Administration (FDA) has granted approval of 5 new prescription medications that are labeled for use ...
Rezolute Reports Fourth Quarter And Full Year Fiscal 2024 Financial Results And Provides Business Update
Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the“Company”), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today ...